Bicocca Open Archive

Logo unimib boa
CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.866
EU - Europa 6.124
AS - Asia 2.992
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 21
AF - Africa 16
Totale 20.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.671
DE - Germania 1.248
IT - Italia 1.120
SG - Singapore 1.099
CN - Cina 1.045
SE - Svezia 962
IE - Irlanda 830
RU - Federazione Russa 558
UA - Ucraina 503
GB - Regno Unito 305
HK - Hong Kong 275
CA - Canada 188
FI - Finlandia 158
VN - Vietnam 150
AT - Austria 118
IN - India 112
FR - Francia 102
KR - Corea 78
JP - Giappone 72
DK - Danimarca 70
ID - Indonesia 46
TR - Turchia 38
BE - Belgio 37
NL - Olanda 32
AU - Australia 22
IR - Iran 21
PL - Polonia 21
EU - Europa 20
NZ - Nuova Zelanda 16
BR - Brasile 15
TW - Taiwan 12
RO - Romania 11
EG - Egitto 10
HR - Croazia 8
MY - Malesia 8
BG - Bulgaria 7
IL - Israele 7
PK - Pakistan 7
PT - Portogallo 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
ES - Italia 5
AE - Emirati Arabi Uniti 4
MX - Messico 4
SA - Arabia Saudita 4
CO - Colombia 3
IQ - Iraq 3
LB - Libano 3
LT - Lituania 3
RS - Serbia 3
ZA - Sudafrica 3
A1 - Anonimo 2
GT - Guatemala 2
HU - Ungheria 2
MD - Moldavia 2
NO - Norvegia 2
PH - Filippine 2
SC - Seychelles 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CL - Cile 1
CR - Costa Rica 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
PE - Perù 1
TH - Thailandia 1
VE - Venezuela 1
Totale 20.080
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.459
Singapore 910
Woodbridge 853
Dublin 812
Chandler 808
Frankfurt am Main 699
Houston 612
Wilmington 545
Jacksonville 535
Fairfield 480
Milan 447
Dearborn 436
Ashburn 432
New York 348
Santa Clara 327
Princeton 282
Hong Kong 255
Seattle 211
Boardman 189
Nanjing 185
Shanghai 149
Cambridge 141
Vienna 118
Beijing 97
Guangzhou 86
Lachine 84
Lawrence 80
Dong Ket 77
Altamura 74
Nanchang 59
Shenyang 59
Helsinki 58
Andover 49
Grafing 45
Jakarta 44
Chicago 43
Toronto 43
Falls Church 42
Fremont 40
Pune 40
San Diego 39
Carate Brianza 35
Nürnberg 35
Jinan 34
Los Angeles 34
Jiaxing 32
Brussels 31
Tianjin 29
Kunming 28
Ottawa 28
Melzo 26
Norwalk 26
Changsha 25
Rome 25
Daejeon 24
Zhengzhou 24
Hangzhou 23
Mountain View 22
Sacramento 22
Shangdi 22
London 21
Tokyo 21
Bergamo 18
Hebei 18
Codroipo 17
Dallas 16
Hefei 15
Ningbo 15
Leawood 14
Lissone 14
Mainz 14
Edmonton 13
Huizen 13
Washington 13
Kraków 12
Seoul 12
Shinjuku 12
Taizhou 12
Auburn Hills 11
Lappeenranta 11
San Mateo 11
Sesto San Giovanni 11
Florence 10
Kiev 10
Phoenix 10
Romola 10
Canazei 9
Wuhan 9
Bologna 8
Cagliari 8
Paris 8
Boston 7
Fuzhou 7
Kuala Lumpur 7
Trieste 7
Ahmedabad 6
Ardabil 6
Changchun 6
Como 6
Detroit 6
Totale 14.271
Salva come PNG Salva come JPEG
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 370
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 302
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 298
Age-related changes in the function and structure of the peripheral sensory pathway in mice 296
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 239
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 235
Enhanced brain targeting of engineered solid lipid nanoparticles 233
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 217
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 215
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 208
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 208
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 208
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 204
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 203
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 199
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 197
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 196
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 195
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 189
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 185
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 184
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 184
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 183
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 183
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 181
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 180
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 177
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 177
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 175
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 174
Enhanced brain targeting of engineered solid lipid nanoparticles 173
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 172
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 171
OCT2 transporter involvement in development of cisplatin toxicity 171
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 171
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 170
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 168
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 168
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 167
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 163
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 163
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 163
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 162
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 162
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 161
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 160
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 158
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 158
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 158
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 158
The neuroprotective effect of erythropoietin (EPO) and of its non-erythropoietic carbamylated derivative (CEPO) in cisplatin-induced peripheral neurotoxicity 156
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 156
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 155
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 154
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 153
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 153
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation 152
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 151
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 151
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 148
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 146
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 144
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 139
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 139
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 137
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 137
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 135
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 135
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 134
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 131
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 130
Multimodal experimental approach to the study of human neurological diseases 129
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 128
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 128
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 128
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 128
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 127
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 127
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 126
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 126
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 125
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 125
Genetic factors influencing the development of vincristine-induced neurotoxicity 124
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 123
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 123
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 123
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 122
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 121
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 120
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 120
Effect of proteasome inhibition on the central and peripheral nervous system 120
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 119
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 115
Glutamate Carboxypeptidase II inhibition in several rat models of chemotherapy-induced peripheral neurotoxicity 115
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 115
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 112
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat 111
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 110
EVALUATION OF THE CONTINUOUS BUPRENORPHINE DELIVERY ANALGESIC EFFECT IN AN EXPERIMENTAL RAT MODEL OF PAINFUL DIABETIC NEUROPATHY 109
Glutamate Carboxypeptidase II (GCPII, NAALADASE) inhibition protects against Cisplatin-induced peripheral neurotoxicity in a rat model. 109
Totale 16.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.094 0 0 0 0 273 389 480 175 266 254 212 45
2020/20212.832 140 129 318 276 235 254 314 247 241 217 178 283
2021/20221.893 132 194 143 200 168 212 91 89 91 133 144 296
2022/20233.477 363 887 321 358 276 535 61 176 277 56 103 64
2023/20242.911 97 106 106 134 345 709 519 176 136 65 65 453
2024/20252.766 385 826 683 331 541 0 0 0 0 0 0 0
Totale 21.170